Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

FDA takes first step toward ending animal testing as part of ‘3.0 modernization'
Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.
GenAI adopters tentative now but confident soon: Survey
GenAI initiatives are complex and—in some cases—costly. “As such, the main rationale for pursuing them needs to be business growth, not workforce reductions.”
Consumers nudge providers to improve patient engagement—personally and digitally
The authors of the survey report note that AI tools mentioned by respondents run the gamut from automated appointment reminders to dynamic “care gap” messaging.
Healthcare AI newswatch: Silent AI threats, overeager clinical AI, trustworthy AI therapists, more
Some AI decision-support models have a proclivity for recommending aggressive care pathways. And doing so on the basis of patient demographics, not medical necessity.
Q&A: Rising cancer rates in young people exacerbated by provider shortage
In exclusive interviews, HealthExec spoke with the American Cancer Society about rising cancer rates, and a virtual provider service that's working to bolster struggling oncology staff.

POCUS access: Urban oases, rural deserts

Fewer than 40% of rural counties in the U.S. can offer residents any access to point-of-care ultrasound, while nearly 90% of their metropolitan counterparts have POCUS aplenty.

MRI confirmed as gold standard for pre-biopsy detection of prostate cancer—but that’s ‘not the end of the story’

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

Low back imaging: All-in-one MR makes strong showing vs. added CT

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

Radiology operation loses standing to provide mammography services

The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.

IDE granted for clinical research of MRI-guided focused ultrasound

The FDA has cleared a focused-ultrasound developer to compare the safety and efficacy of acoustic energy for treating prostate cancer against the more conservative approach of active surveillance.

RSNA flagship journal soars in influence; Lancet bumps NEJM on strength of pandemic publishing

Editor David Bluemke, MD, PhD, says the journal’s rising impact factor is “representative of the fundamental importance of imaging throughout our hospitals and clinics.”

Philips picks partner for multispecialty management of lung cancer

An imaging OEM is teaming with a multi-omics diagnostics company to offer lung-cancer care teams lab data alongside radiologic findings and clinical histories.

Big private payer reverses course on cardiac PET/CT coverage

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality.

Business Intelligence

FDA takes first step toward ending animal testing as part of ‘3.0 modernization'

GenAI adopters tentative now but confident soon: Survey

Consumers nudge providers to improve patient engagement—personally and digitally

Healthcare AI newswatch: Silent AI threats, overeager clinical AI, trustworthy AI therapists, more

Q&A: Rising cancer rates in young people exacerbated by provider shortage